Wei‐Fu Lv
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
Papers in
- Hepatology 24
- Liver Disease and Transplantation 13
- Hepatocellular Carcinoma Treatment and Prognosis 12
-
- Gallbladder and Bile Duct Disorders 4
- Co-authors
- Chunze Zhou (18 shared papers)Ping Xu (2 shared papers)Wei Wei (1 shared paper)Dong Lu (10 shared papers)Wenjing Tang (2 shared papers)Yusheng He (1 shared paper)Yucai Wang (3 shared papers)Weiwei Fang (5 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Hepatology International (3 papers)Drug Design Development and Therapy (3 papers)CardioVascular and Interventional Radiology (2 papers)Medicine (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Wei‐Fu Lv
49 papers receiving 623 citations
Peers
Comparison fields: 5 of 79
- Hepatology 169
- Infectious Diseases 112
- Radiology, Nuclear Medicine and Imaging 99
- Health Informatics 6
- Pulmonary and Respiratory Medicine 90
Countries citing papers authored by Wei‐Fu Lv
This map shows the geographic impact of Wei‐Fu Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Fu Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Fu Lv more than expected).
Fields of papers citing papers by Wei‐Fu Lv
This network shows the impact of papers produced by Wei‐Fu Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Fu Lv. The network helps show where Wei‐Fu Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Fu Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 169 | |
| 2 | 2016 | 41 | |
| 3 | 2022 | 38 | |
| 4 | 2021 | 28 | |
| 5 | 2018 | 22 | |
| 6 | Predictive accuracy comparison of MELD and Child-Turcotte-Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review. | 2015 | 21 |
| 7 | Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma. | 2014 | 21 |
| 8 | 2020 | 19 | |
| 9 | 2022 | 18 | |
| 10 | 2019 | 18 | |
| 11 | 2015 | 17 | |
| 12 | 2024 | 17 | |
| 13 | 2019 | 14 | |
| 14 | 2018 | 14 | |
| 15 | 2023 | 13 | |
| 16 | 2017 | 12 | |
| 17 | 2015 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2023 | 9 | |
| 20 | 2022 | 8 |
About Wei‐Fu Lv
Wei‐Fu Lv is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Pathology and Forensic Medicine, having authored 52 papers that have together received 635 indexed citations. Recurring topics across this work include Liver Disease and Transplantation (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Gallbladder and Bile Duct Disorders (4 papers), Cancer Mechanisms and Therapy (3 papers), Nanoplatforms for cancer theranostics (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Hepatology (169 citations), Infectious Diseases (112 citations), Radiology, Nuclear Medicine and Imaging (99 citations), Health Informatics (6 citations) and Pulmonary and Respiratory Medicine (90 citations). Wei‐Fu Lv has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Chunze Zhou, Ping Xu, Wei Wei, Dong Lu, Wenjing Tang, Yusheng He, Yucai Wang, Weiwei Fang, Ruifeng Wang and Wei Jiang. Their work appears in journals such as Journal of Clinical Oncology, Hepatology International, Drug Design Development and Therapy, CardioVascular and Interventional Radiology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.